Unsubscribe Success – Labcorp

Why Test
Enhancing Health Equity
Contact

Thank you.

We have received your request to remove your email address from our program.

Through this program, Labcorp will perform testing using Labcorp’s lab-developed APOL1 Genotype Test. Each patient that meets the eligibility criteria will receive one Labcorp APOL1 Genotype Test and will have access to genetic counseling at no cost. No patients, providers, and/or third-party payers (including commercial health plans and government health care programs) will be billed for the APOL1 testing covered under the program. The ordering physician will not receive any fees or compensation from Labcorp or Vertex Pharmaceuticals in connection with the Labcorp APOL1 Genotyping Program, such as for specimen collection, handling, or data reporting. Patients meeting the above eligibility criteria, as well as their treating health care providers, are not required to order, purchase, prescribe, and/or obtain any other product or service from Vertex Pharmaceuticals, Labcorp or any of their affiliates. Labcorp and Vertex Pharmaceuticals reserve the right to rescind, revoke, or amend the program for any reason without notice. Program is not valid where prohibited by law. This program is subject to change or discontinuation without notice. Additional terms and conditions apply. No identifiable patient or provider data will be shared with Vertex Pharmaceuticals as part of this program.

For any questions, contact our Clinical Program Coordinator at 855-610-6115.

Privacy Statement | Terms and Conditions | Notice of Nondiscrimination | Combatting Modern Slavery and Human Trafficking Statement

©2025 Labcorp. All rights reserved.